Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,944Revenue $M1,292Net Margin (%)-30.9Altman Z-Score5.6
Enterprise Value $M19,885EPS $-1.6Operating Margin %-23.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-30.2Higher ROA y-yY
Price/Book20.810-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales15.15-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-42.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M247ROIC % (ttm)-47.7Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2016-03-31 Add0.5%$78.4 - $125.83
($91.01)
$ 80.63-11%Add 28.91%12,668,241
VRTXKen Fisher 2016-03-31 Reduce$78.4 - $125.83
($91.01)
$ 80.63-11%Reduce -7.00%5,155
VRTXVanguard Health Care Fund 2015-12-31 Add0.1%$109.03 - $133.26
($121.16)
$ 80.63-33%Add 4.34%9,827,411
VRTXJohn Paulson 2015-12-31 Buy 0.04%$109.03 - $133.26
($121.16)
$ 80.63-33%New holding46,400
VRTXJoel Greenblatt 2015-12-31 Buy 0.02%$109.03 - $133.26
($121.16)
$ 80.63-33%New holding11,793
VRTXKen Fisher 2015-12-31 Add$109.03 - $133.26
($120.93)
$ 80.63-33%Add 12.48%5,543
VRTXVanguard Health Care Fund 2015-09-30 Reduce-0.03%$98.5 - $141.48
($128.47)
$ 80.63-37%Reduce -1.21%9,418,411
VRTXKen Fisher 2015-09-30 Add$98.5 - $141.48
($128.47)
$ 80.63-37%Add 12.56%4,928
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 80.63-36%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 80.63-36%Reduce -0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 80.63-33%Reduce -2.80%9,533,911
VRTXGeorge Soros 2015-03-31 Buy 0.07%$107.88 - $134.25
($119.81)
$ 80.63-33%New holding56,912
VRTXKen Fisher 2015-03-31 Add$107.88 - $134.25
($119.81)
$ 80.63-33%Add 0.18%4,386
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 80.63-28%Reduce -16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 80.63-15%Reduce -31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 80.6315%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 80.6316%Sold Out0
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 80.6316%New holding6,753
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 80.632%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 80.632%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2016-04-27Sell5,130$83.67-3.63view
BOGER JOSHUA SDirector 2016-04-20Sell5,130$84.1-4.13view
BOGER JOSHUA SDirector 2016-04-13Sell5,130$84.27-4.32view
BOGER JOSHUA SDirector 2016-04-06Sell5,130$89.56-9.97view
BOGER JOSHUA SDirector 2016-03-30Sell5,130$78.832.28view
BOGER JOSHUA SDirector 2016-03-23Sell5,130$81.38-0.92view
BOGER JOSHUA SDirector 2016-03-16Sell5,130$79.651.23view
BOGER JOSHUA SDirector 2016-03-09Sell5,130$85.34-5.52view
BOGER JOSHUA SDirector 2016-03-02Sell5,130$91.8-12.17view
BOGER JOSHUA SDirector 2016-02-24Sell5,130$85.25-5.42view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
    Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 

    More From Other Websites
    Inside Soliris’s Continued Growth Momentum May 04 2016
    Facebook, First Solar and Vertex are first-quarter sales winners May 04 2016
    A Promising Uptake for Vertex’s Orkambi May 04 2016
    A Look at Vertex’s Cystic Fibrosis Patient Opportunity May 04 2016
    VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report May 03 2016
    Investing in biotech May 03 2016
    How Did Vertex Perform in 1Q16? May 03 2016
    ETF’s with exposure to Vertex Pharmaceuticals, Inc. : May 2, 2016 May 02 2016
    Does Vertex Have a Significant Upside? May 02 2016
    By How Much Did Vertex’s Revenue and Earnings Miss in 1Q16? May 02 2016
    How Analysts View Vertex After Earnings May 01 2016
    Vertex cut CEO pay by 23% last year amid executive-pay overhaul Apr 29 2016
    A Typical Bad First Quarter For Biotech: Leerink Apr 29 2016
    Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 29 2016
    Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US :... Apr 29 2016
    Vertex aims at not only new patients, but on keeping those they have Apr 28 2016
    Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel,... Apr 28 2016
    Short Sellers Dump Vertex, Load Up On Baxalta Apr 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)